More and more families are banking their baby’s cord tissue.
Cord tissue cells are different than cord blood cells and could benefit your family.
We understand banking your baby's cord tissue is an investment in your family's future. That's why we invested in a processing technology that delivers more value for families. It starts from the minute your baby's cord tissue arrives at ViaCord's AABB Accredited Laboratory.
We’re proud to be one of the few family banks to receive AABB (American Association of Blood Banks) accreditation for processing and storing newborn stem cells from both cord blood and cord tissue. Accreditation validates the quality of our service and is one of the many reasons families feel confident about choosing ViaCord. View our accreditation certificate here.
Putting Your Family In The Best Position Possible.
Since we extract cord tissue cells prior to freezing and storage, your cells will be ready to use if needed. Some banks simply store segments of the cord tissue, without extracting the stem cells first, resulting in a final product that is not ready for use.
Here's How ViaCord Delivers More Value
We Recover All Cell Types
We recover all cell types from all regions of the cord. Cell types include: mesenchymal, endothelial, epithelial, neuronal, hematopoietic, perivascular.
We recover cells prior to freezing them for storage. Our method results in 8x the number of cord tissue stem cells available for treatment compared to other methods that extract cells from thawed frozen segments of cord tissue. 14
Your cells will be processed, characterized (required by treating physicians) and stored in a 5-compartment bag. This means they are ready for use if needed. Clinical use requires cells, not tissue. And our multi-compartment bag gives your family more options and greater flexibility.
Treatment potential for cord tissue stem cells.
Researchers are exploring areas of potential use for cartilage, muscle, and nerve conditions including Parkinson’s disease, lung cancer, sports injuries, and autism.20,25,26,126 A Phase I clinical trial is currently underway at Duke University Medical Center to determine the safety of using cord tissue stem cells in children with autism.
It’s important to note, these studies use fresh stem cells that were extracted from the cord tissue. These studies did not utilize frozen cord tissue or cells extracted from tissue that had been cryopreserved.